Federal Funding Opportunities

Winship investigators have access to an extensive listing of cancer-related funding issued by the National Institutes of Health and other federal agencies. The listing updates automatically on a daily basis.

Use the column sorting, search filtering, and pagination tools to find and select federal funding opportunities below.

Cascade Link
OpportunityPostedClosing

Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/07/2009/24/20

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)

Agency: NIH

Institutions: NCCIHNCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIEHSNIGMSNIMHNIMHDNINDSNLMNINRORIP

07/06/2005/07/23

National Public Health Surveillance for Chemical and Radiologic Exposures and Emerging Drug Threats - COVID-19 Supplemental

Agency: NCEH

07/02/2008/19/20

Aging, Cancer-Initiating Cells, and Cancer Development (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIA

07/02/2002/17/21

DoD Pancreatic Cancer, Translational Research Partnership Award

Agency: AMRAA

07/01/2011/20/20

DoD Pancreatic Cancer, Idea Development Award

Agency: AMRAA

07/01/2011/20/20

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

06/30/2005/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Senior Fellowship (Parent F33)

Agency: NIH

06/30/2005/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)

Agency: NIH

06/29/2005/07/23

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Agency: NIH

06/29/2008/08/23

Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

06/29/2011/19/20

Women’s Preventive Services Initiative

Agency: HRSA

06/29/2010/05/20

3D Technologies to Accelerate HTAN Atlas Building Efforts (UH2 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

06/25/2011/09/20

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)

Agency: NIH

06/23/2005/07/23

Interventions to Prevent Electronic Nicotine Delivery Systems (ENDS) Use Among Adolescents (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCIODPOBSSR

06/16/2010/19/20

Emergency Awards: RADx-UP Coordination and Data Collection Center (CDCC) (U24 Clinical Trial Optional)

Agency: NIH

Institutions: ODNIMHDNIANEINHLBINHGRINIAMSNIBIBNICHDNIDCDNIDCRNIDANIEHSNIGMSNIMHNINRNLMFICNCCIHNCATSNCISGMROTHROODPOBSSRORWH

06/12/2008/07/20

Improving Smoking Cessation Interventions among People Living with HIV (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDANIMHD

06/10/2009/04/20

Improving Smoking Cessation Interventions among People Living with HIV (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDA

06/10/2009/04/20

Administrative Supplement for Research on Dietary Supplements (Admin Supp-Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINEINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIEHSNIMHDFICNCCIHORIP

06/09/2004/15/23

Enhancing Public Health Laboratory Capabilities and Increasing Capacity

Agency: CSELS

06/05/2007/20/20

Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAID

06/05/2007/22/20

Emergency Awards: SARS-CoV-2 Serological Sciences Centers of Excellence (U54 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAID

06/05/2007/22/20

Increasing Public Awareness and Provider Education About Primary Immunodeficiency Disease

Agency: CSELS

06/04/2007/10/20

DoD Kidney Cancer, Idea Development Award

Agency: AMRAA

06/04/2009/23/20

DoD Kidney Cancer, Postdoctoral and Clinical Fellowship Award

Agency: AMRAA

06/03/2009/23/20

DoD Kidney Cancer, Clinical Consortium – Clinical Trial Site Award

Agency: AMRAA

06/03/2009/23/20

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR

06/03/2003/17/23

Mid-Career Enhancement Awards to Integrate Basic Behavioral, Biomedical, and/or Social Scientific Processes (K18 No Independent Clinical Trials)

Agency: NIH

Institutions: OPPNETNIAAANIEHSNIMHNIMHDNCCIHNCIOBSSR

06/03/2003/17/23

Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIP

05/29/2005/07/23

NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)

Agency: NIH

Institutions: NCCIHODS

05/20/2005/07/23

NCCIH Natural Product Mid Phase Clinical Trial Cooperative Agreement (U01 Clinical Trial Required)

Agency: NIH

Institutions: NCCIH

05/20/2005/07/23

Metastasis Research Network (U54 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

05/13/2005/28/21

DoD Kidney Cancer, Translational Research Partnership Award

Agency: AMRAA

05/12/2008/26/20

DoD Kidney Cancer, Academy of Kidney Cancer Investigators – Early-Career Investigator Award

Agency: AMRAA

05/12/2008/26/20

DoD Kidney Cancer, Concept Award

Agency: AMRAA

05/12/2008/05/20

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCCIHNCINHLBINHGRINIANIAAANIBIBNICHDNIDCDNIDCRNIDANIMHNINDSNIEHSNIMHD

05/12/2005/07/23

Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)

Agency: NIH

05/12/2005/07/23

NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNIMHDNLMNCCIHNCATSORIPNCI

05/08/2005/07/23

DoD Prostate Cancer, Prostate Cancer Pathology Resource Network Award

Agency: AMRAA

05/08/2009/24/20

NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIHNEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDANIEHSNINRNIMHDNLMNCCIHNCIICs

05/07/2005/07/23

NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAMSNIBIBNICHDNIDANCCIHNIDDKNIEHSNIMHNINDSNINRNIMHD

05/05/2005/07/23

NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIHNEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIPNCIICs

05/05/2005/07/23

NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: NCINEINIANIAAANICHDNIDCDNIDCRNIDANIEHSNIMHNIMHDNINDSNINRNCCIH

05/05/2005/07/23

NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIAIDNIBIBNCCIHNICHDNIDANIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNLMORIPNIMHD

05/05/2005/07/23

Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNIANIDCDNIDANIMHNINRNIMHDNCCIHNCIOBSSR

04/30/2009/07/23

Advancing Research to Develop Improved Measures and Methods for Understanding Multimorbidity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNIANIDCDNIDCRNCCIHNCI

04/30/2009/07/23

DoD, Breast Cancer, Breakthrough Award Level 3

Agency: AMRAA

04/30/2010/06/20

DoD, Breast Cancer, Innovator Award

Agency: AMRAA

04/30/2010/06/20

DoD, Breast Cancer, Breakthrough Award Level 4

Agency: AMRAA

04/30/2010/06/20

DoD, Breast Cancer, Transformative Breast Cancer Consortium Award

Agency: AMRAA

04/30/2010/06/20

DoD, Breast Cancer, Breakthrough Award Levels 1 and 2

Agency: AMRAA

04/30/2009/22/20

DoD, Breast Cancer, Era of Hope Scholar Award

Agency: AMRAA

04/30/2009/22/20

Mucosal Immunology Studies Team (MIST) (U01 Clinical Trial Not Allowed).

Agency: NIH

Institutions: NIAID

04/24/2010/09/20

DoD Melanoma, Idea Award

Agency: AMRAA

04/21/2009/24/20

DoD Melanoma, Technology Development Partnership Award

Agency: AMRAA

04/21/2009/24/20

Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNIANIDANCI

04/20/2009/07/23

New Informatics Tools and Methods to Enhance U.S. Cancer Surveillance Research (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/15/2006/06/23

Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHGRINIAIDNIDCDNIDCRNIDDKNIDANIEHSNIMHNINDSNINR

04/15/2008/28/20

Strengthening Institutional Capacity to Conduct Global Cancer Research in Low- and Middle-Income Countries (D43 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

04/14/2006/24/21

Limited Competition: International Epidemiology Databases to Evaluate AIDS (IeDEA) (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNHLBINIAAANICHDNIDDKNIDANIMHFICNCI

04/08/2008/04/20

DoD Prostate Cancer, Health Disparity Research Award

Agency: AMRAA

04/07/2007/16/20

DoD Prostate Cancer, Translational Science Award

Agency: AMRAA

04/07/2007/16/20

DoD Prostate Cancer, Clinical Trial Award

Agency: AMRAA

04/07/2007/16/20

DoD Prostate Cancer, Population Science and Outcomes Research Award

Agency: AMRAA

04/07/2007/16/20

DoD Prostate Cancer, Idea Development Award

Agency: AMRAA

04/07/2009/24/20

Cyber-Physical Systems

Agency: NSF

04/07/2012/02/20

Mechanisms and Consequences of Sleep Disparities in the U.S. (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNHLBINIANIAAANINDSNCI

04/03/2007/14/22

CDMRP Ovarian Cancer Proteogenomics Research Award

Agency: AMRAA

04/02/2007/30/20

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIBNIDCR

03/30/2009/07/22

NIDA Small Research Grant Program (R03 Clinical Trial Required)

Agency: NIH

Institutions: NIDA

03/24/2005/07/23

Exploiting in vivo or in situ imaging approaches to understand HIV-relevant processes in the context of substance use disorders (R61/R33 Clinical Trials Optional)

Agency: NIH

Institutions: NIDA

03/24/2008/13/20

DoD Gulf War Illness, Idea Award

Agency: AMRAA

03/24/2009/10/20

DoD Gulf War Illness, Clinical Evaluation Award

Agency: AMRAA

03/24/2009/10/20

DoD Gulf War Illness, Patient-Provider and Health Communications Award

Agency: AMRAA

03/24/2009/10/20

DoD Gulf War Illness, New Investigator Award

Agency: AMRAA

03/24/2009/10/20

DoD Gulf War Illness, Research Advancement Award

Agency: AMRAA

03/24/2009/10/20

DoD Peer Reviewed Cancer Research, Behavioral Health Science Award

Agency: AMRAA

03/23/2008/27/20

DoD Peer Reviewed Cancer Research, Impact Award

Agency: AMRAA

03/23/2008/27/20

DoD Peer Reviewed Cancer Research, Idea Award

Agency: AMRAA

03/23/2008/27/20

DoD Peer Reviewed Cancer Research, Translational Team Science Award

Agency: AMRAA

03/23/2008/27/20

DoD Peer Reviewed Cancer Research, Career Development Award

Agency: AMRAA

03/23/2008/20/20

DoD Peer Reviewed Cancer Research, Virtual Cancer Center Director Award

Agency: AMRAA

03/23/2008/20/20

DoD Lung Cancer, Career Development Award

Agency: AMRAA

03/23/2008/05/20

DoD Lung Cancer, Clinical Translational Research Partnership Award

Agency: AMRAA

03/23/2008/05/20

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Agency: NIH

Institutions: NCINEINHGRINHLBINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDDKNIDANIEHSNIGMSNIMHNINRNCCIHORIP

03/20/2005/25/23

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/16/2007/30/21

Research to Reduce Morbidity and Improve Care for Pediatric, and Adolescent and Young Adult (AYA) Cancer Survivors (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/16/2007/30/21

DoD Lung Cancer, Idea Development Award

Agency: AMRAA

03/12/2008/05/20

DoD Lung Cancer, Investigator-Initiated Translational Research Award

Agency: AMRAA

03/12/2008/05/20

Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/12/2005/07/23

Core Infrastructure Support for Cancer Epidemiology Cohorts (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/12/2011/09/22

Gastrointestinal (GI) and Microbiome Explorers: Development of Swallowable Smart Pills or Devices for Precision Nutrition, Microbiome and Digestive Disease Applications (R21/R33 Clinical Trial Required)

Agency: NIH

Institutions: NIDDKNCI

03/11/2006/08/21

Development of Wearable Smart Devices for Continuous Monitoring of Circulating Nutrients, Metabolites and Hormones (R21/R33 Clinical Trial Required)

Agency: NIH

Institutions: NIDDKNCI

03/11/2006/08/21

Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)

Agency: NIH

Institutions: NCINCCIHNHGRINIAIDNICHDNIDDKNIEHSNIGMSNIMH

03/10/2009/07/25

Engineering Immunity to HIV-1 Through Next Generation Vaccines (R61/R33 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

03/09/2007/28/20

Harnessing Natural Killer (NK) Cells to Prevent, Control, or Eradicate HIV (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNIMH

03/06/2007/28/20

SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/06/2008/03/20

Research Towards Developing a Cure for HBV in HIV/HBV Co-Infection (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

03/06/2001/07/22

Native American Research Centers for Health (NARCH) (S06 Clinical Trial Optional)

Agency: NIH

Institutions: NIGMSNCINHLBINHGRINIANIAIDNIAMSNIDCRNIDDKNIDANIMHDNCCIHORWH

03/05/2007/23/21

CDMRP Ovarian Cancer Research Program Clinical Translational Research Award

Agency: AMRAA

02/27/2007/30/20

CDMRP Ovarian Cancer Research Program Pilot Award

Agency: AMRAA

02/27/2007/30/20

CDMRP Ovarian Cancer Research Program Investigator-Initiated Research Award

Agency: AMRAA

02/27/2007/30/20

CDMRP Ovarian Cancer Research Program Ovarian Cancer Academy – Early-Career Investigator Award

Agency: AMRAA

02/27/2007/30/20

Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/24/2011/18/21

Molecular Mechanisms of Combination Adjuvants (MMCA) (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

02/06/2007/20/20

Developmental Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC

02/03/2007/28/22

Centers for AIDS Research (P30 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAIDNCINHLBINIANICHDNIDCRNIDDKNIDANIMHNINRNIMHDFIC

02/03/2007/28/22

National Cancer Institute Program Project Applications (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/27/2005/07/23

Genomic Expert Curation Panels (U24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNEINIMHNINDSNCI

01/23/2005/26/22

Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Biostatistics Research Center (BRC) (Collaborative U01 Clinical Trial Required)

Agency: NIH

Institutions: NIDDKNIANCI

01/23/2007/22/20

Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) Clinical Centers (Collaborative U01 Clinical Trial Required)

Agency: NIH

Institutions: NIDDKNIANCI

01/23/2007/22/20

HIV/AIDS and the Tumor Niche (U54 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

01/23/2007/15/20

Development of Innovative Informatics Methods and Algorithms for Cancer Research and Management (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Revision Applications to Support the Application of Informatics Technology for Cancer Research (R01 Clinical Trials Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Revision Applications to Support the Application of Informatics Technology for Cancer Research (U01 Clinical Trials Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Revision Applications to Support the Application of Informatics Technology for Cancer Research (U24 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/23/2011/18/20

Biomedical Knowledgebase (U24 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI

01/17/2005/08/23

Biomedical Data Repository (U24 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NIGMSNIAAANIAIDNIDANIEHSNINDSNIMHDNCI

01/17/2005/08/23

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/16/2011/17/20

Research Answers to National Cancer Institute's (NCI) Provocative Questions (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/16/2011/17/20

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

01/14/2004/01/22

Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

01/14/2004/01/22

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U2C Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (U54 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/20/1909/29/20

Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/10/1910/28/22

NIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

12/09/1909/07/22

Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

12/04/1909/29/20

Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R21 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

12/04/1909/29/20

Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

12/04/1909/29/20

Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

12/04/1909/29/20

Co-infection and Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/22/1901/07/23

Co-infection and Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/22/1901/07/23

NIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

11/22/1901/07/23

Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

11/12/1901/07/23

Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

11/12/1905/11/21

NCI Small Grants Program for Cancer Research for Years 2020, 2021, and 2022 (NCI Omnibus R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/08/1901/07/23

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

11/04/1909/25/22

Integrative Research on Polysubstance Abuse and Disorder (R61/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCI

10/18/1911/07/22

Fundamental Mechanisms of Affective and Decisional Processes in Cancer Control (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/18/1901/07/23

HIV-associated Non-Communicable Diseases Research at Low- and Middle-Income Country Institutions (R21 Clinical Trial Optional)

Agency: NIH

Institutions: FICNIAMSNIDDKNIMHNCI

10/18/1912/03/20

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI

10/04/1909/08/22

HEAL Initiative: Development of Therapies and Technologies Directed at Enhanced Pain Management (R41/R42 Clinical Trial Required)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI

10/04/1909/08/22

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Required)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIBIBNICHDNIDDKNIGMSNIMHNINRNIMHDNCCIHNCI

10/04/1909/08/22

HEAL INITIATIVE: Development of Therapies and Technologies Directed at Enhanced Pain Management (R43/R44 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNEINHLBINIANIAAANIAMSNIBIBNICHDNIDCRNIDDKNIGMSNIMHNINRNIMHDNLMNCCIHNCATSORIPNCI

10/04/1909/08/22

Perception and Cognition Research to Inform Cancer Image Interpretation (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

10/02/1901/07/23

Perception and Cognition Research to Inform Cancer Image Interpretation (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIBIB

10/02/1901/07/23

Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: OPPNETNEINIANIAAANIAMSNICHDNIDCDNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR

09/18/1903/17/21

Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required)

Agency: NIH

Institutions: OPPNETNEINIANIAAANICHDNIDCDNIDANIMHNINDSNINRNIMHDNCCIHNCIOBSSR

09/18/1903/17/21

Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)

Agency: NIH

Institutions: FICNIBIBNICHDNIDCDNIMHNINDSNCIOBSSRORWH

09/13/1912/03/20

Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNHLBINIDCRNCI

09/12/1901/07/23

Stimulating Access to Research in Residency Transition Scholar (StARRTS) (K38) (Clinical Trial Not Allowed)

Agency: NIH

Institutions: NHLBINCINIANIAID

09/09/1901/14/22

Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANIAAA

09/09/1909/07/21

Revision Applications for Mechanisms of Drug Resistance (U54 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/06/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (P01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (P50 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Revision Applications for Mechanisms of Drug Resistance (U01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1906/23/21

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/05/1905/07/21

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

09/03/1901/10/22

Myeloid-Derived Suppressor Cells (MDSCs) as Potential Therapeutic Targets in TB/HIV (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

09/03/1901/10/22

Small-Cell Lung Cancer (SCLC) Consortium: Therapeutic Development and Mechanisms of Resistance (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/29/1903/11/22

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Intervening with Cancer Caregivers to Improve Patient Health Outcomes and Optimize Health Care Utilization (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1909/07/22

Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R03 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/29/1907/16/22

NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/28/1907/20/22

Neural Regulation of Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/28/1905/27/22

Neural Regulation of Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

08/28/1905/27/22

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/16/1906/08/22

Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/16/1906/08/22

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

08/16/1907/16/22

Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

08/16/1909/07/22

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/12/1906/08/22

Leveraging Cognitive Neuroscience to Improve Assessment of Cancer Treatment-Related Cognitive Impairment (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/12/1906/08/22

SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, R44) Clinical Trial Not Allowed

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAMSNIBIBNIDCDNIDCRNIDDKNIEHSNIGMSNIMHNINDSNINRNCATS

08/05/1904/05/22

Human Exploration Research Opportunities (HERO)

Agency: JSC

07/31/1909/04/20

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/30/1902/11/22

Participant Engagement and Cancer Genome Sequencing (PE-CGS): Research Centers (U2C Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/26/1910/30/20

Maximizing the Scientific Value of Existing Biospecimen Collections: Scientific Opportunities for Exploratory Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINHLBINIAAANIDANIEHSCTP

07/08/1903/08/21

Stimulating Innovations in Behavioral Intervention Research for Cancer Prevention and Control (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1909/07/22

Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and/or Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIAID

06/28/1901/14/22

Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIA

06/25/1907/16/22

Early-Stage T1 Translational Aging Research (Bench to Bedside) for the Development of Novel Therapeutics (R21/R33 Clinical Trial Optional)

Agency: NIH

Institutions: NIA

06/25/1907/16/22

Interaction of Ionizing Radiation with Matter University Research Alliance (IIRM-URA)

Agency: DTRA

05/30/1909/30/20

Research Projects in Cancer Systems Biology (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/22/1911/15/21

Postdoctoral Research Associate Training (PRAT) Program (Fi2)

Agency: NIH

Institutions: NIGMS

05/21/1910/04/21

Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional)

Agency: NIH

Institutions: FICNCINIDANIMH

05/14/1908/20/21

Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/13/1911/15/20

Provocative Questions (PQs) in Multiple Myeloma Disparities Research (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/13/1911/15/20

Exploratory Grants in Cancer Epidemiology (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/08/1910/08/21

Dissemination and Implementation Research in Health (R03 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINHGRINIANIAAANICHDNIDCRNIDANIEHSNIMHNINDSFICODPOBSSRORWH

05/08/1905/07/22

Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHLBINHGRINIANIAAANIAIDNIAMSNICHDNIDCDNIDCRNIDANIEHSNIMHNINDSNINRNIMHDNCCIHODPOBSSRORWH

05/08/1905/07/22

Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINHGRINIANIAAANIAIDNIAMSNIDCDNIDANIEHSNIMHNINDSNINRFICNCCIHODPOBSSRORWH

05/08/1905/07/22

Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Aggressive Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/01/1912/10/21

Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIEHS

04/11/1911/08/21

Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIEHS

04/11/1911/08/21

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/08/1906/17/21

Feasibility and Planning Studies for Development of Specialized Programs of Research Excellence (SPOREs) to Investigate Cancer Health Disparities (P20 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

03/13/1910/18/20

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Mechanisms Underlying the Contribution of Sleep Disturbances to Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCCIHNCINHLBINIANIAAANIDANIDCRNINDSNINROBSSRORWH

02/28/1905/07/22

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/27/1911/08/21

Modulating Intestinal Microbiota to Enhance Protective Immune Responses against Cancer (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/27/1911/08/21

Microbial-based Cancer Therapy -Bugs as Drugs (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Microbial-based Cancer Therapy -Bugs as Drugs (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/22/1905/07/22

Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)

Agency: NIH

Institutions: NCCIHNCINHGRINHLBINIANIAAANIAMSNICHDNIDCDNIDCRNIDDKNIEHSNIMHNIMHDNINDSNLMORIP

02/22/1901/07/22

Biology of Bladder Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

Biology of Bladder Cancer (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

02/05/1905/07/22

Provocative Questions (PQs) in Cancer with an Underlying HIV Infection (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/24/1908/03/20

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDANIMHDNIMHNCINCCIHORWH

01/09/1909/07/21

Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDANINDSNIMHDNIMHNCINICHDORWH

01/09/1909/07/21

Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIBIBNIAAANIAMSNCINIDCRNIEHSNINDSNIA

01/08/1901/07/22

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

01/08/1901/07/22

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINIAMS

01/08/1901/07/22

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

01/08/1901/07/22

Bioengineering Research Grants (BRG) (R01 Clinical Trial Required)

Agency: NIH

Institutions: NIBIBNCINIANIAAANINDS

01/08/1905/07/21

Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 - Clinical Trial Required)

Agency: NIH

Institutions: NICHDNEININRNIDCDNIDANINDSNHLBINCINIANIMH

12/21/1801/07/21

End-of-Life and Palliative Needs of Adolescents and Young Adults (AYA) with Serious Illnesses (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCI

12/21/1801/07/22

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)

Agency: NIH

Institutions: NINRNCINIANICHDNIDCDNIDANIMHNINDSNHLBI

12/21/1801/07/22

Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINHLBINIANIAIDNIAMSNIBIBNICHDNIDCDNIDANIEHSNIMHNINDSNCCIHNINR

12/21/1801/07/22

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

Improving Outcomes in Cancer Treatment-Related Cardiotoxicity (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/17/1801/07/22

FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for Non-PEPFAR (President's Emergency Plan for AID Relief) Funded Countries

Agency: SUP

12/13/1809/30/20

Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/12/1809/30/20

Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH

12/11/1811/04/20

Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIMHDNCIOBSSR

11/28/1803/04/21

Emerging Global Leader Award (K43 Independent Clinical Trial Required)

Agency: NIH

Institutions: FICNCINHGRINIDCRNIEHSNIMHNINDSORWH

11/02/1811/04/20

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIMHNLMNCATS

10/24/1809/05/21

Commercializing Understudied Proteins from the Illuminating the Druggable Genome Project (IDG) (R41/R42 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIMHNLMNCATS

10/24/1809/05/21

Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIAMSNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNCCIHNCATSNHLBIORIPNICHD

10/17/1802/02/21

Opportunities for Collaborative Research at the NIH Clinical Center (U01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH

10/05/1804/15/21

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

10/05/1803/04/21

Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIMHDNCI

10/05/1803/04/21

Pre-application: Opportunities for Collaborative Research at the NIH Clinical Center (X02 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINEINHLBINHGRINIAAANIAMSNIBIBNIDCDNIDCRNIDANIMHNINDSNCCIHODSORWH

10/05/1812/11/20

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Applying a Biopsychosocial Perspective to Self-Management of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Biobehavioral Basis of Chronic Pain (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNCINIAMSNCCIHOBSSR

10/01/1801/07/22

Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/28/1807/11/21

FY19-FY20 Department of Defense HIV/AIDS Prevention Program: Military Specific HIV/AIDS Prevention, Care, and Treatment Program for PEPFAR (President's Emergency Plan for AIDS Relief) Funded Countries

Agency: SUP

09/28/1809/30/20

Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDCRNIDANIMHNIMHD

09/21/1801/07/22

Developing the Therapeutic Potential of the Endocannabinoid System for Pain Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINCCIHNIAAANICHD

09/10/1809/07/21

Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/07/1808/11/21

Feasibility Studies to Build Collaborative Partnerships in Cancer Research (P20 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

09/05/1811/13/20

Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINCCIHODS

08/14/1809/07/21

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

Physical Activity and Weight Control Interventions Among Cancer Survivors: Effects on Biomarkers of Prognosis and Survival (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

08/07/1809/07/21

Advancing Mechanistic Probiotic/Prebiotic and Human Microbiome Research (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNCINIAMSNIDAODS

07/25/1809/07/21

Biologic Factors Underlying Dental, Oral, and Craniofacial Health Disparities (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIMHD

07/25/1809/07/21

Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

07/24/1803/08/21

Diet and Physical Activity Assessment Methodology (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNCCIH

07/17/1809/07/21

Diet and Physical Activity Assessment Methodology (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINIAAANIMHDNINR

07/17/1809/07/21

Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDDKNCINICHDODPOBSSR

07/12/1809/10/21

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/25/21

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/25/21

Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIMHD

06/29/1806/15/21

Electronic Nicotine Delivery Systems (ENDS): Basic Mechanisms of Health Effects (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODPNCINIDCRNIDANIEHS

06/29/1806/15/21

Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine (U24 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1806/14/21

Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional)

Agency: NIH

Institutions: NCI

06/28/1809/10/20

Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCINEINHGRINIANIAAANIAIDNIBIBNIDCRNIDANIGMSNINDSNINRNIMHDNCCIHNCATS

06/20/1809/04/21

The Role of Epitranscriptomics in Development and Disease (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NICHDNCINEI

06/14/1806/03/21

Administrative Supplements for Validation Studies of Analytical Methods for Dietary Supplement Constituents (Admin Supp - Clinical Trial Not Allowed)

Agency: NIH

Institutions: ODSNCINIDDKNIEHSNCCIH

06/05/1807/15/20

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R41/R42 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/24/1801/05/21

Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional)

Agency: NIH

Institutions: NCI

05/24/1801/05/21

Precision Imaging of Oral Lesions (R01- Clinical Trial Not Allowed)

Agency: NIH

Institutions: NIDCRNIBIBNCI

05/16/1809/07/21

Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

04/30/1801/11/21

Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIAIDNCINIMH

04/20/1805/07/21

Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R01 Clinical Trial Optional).

Agency: NIH

Institutions: NCINIANIDCRNINR

04/03/1805/07/21

Age-related Microbiota Changes and their Implications in Chronic Disease Prevention, Treatment and Progression (R21 Clinical Trial Optional).

Agency: NIH

Institutions: NCINIANIDCRNINR

04/03/1805/07/21

Exploratory Grant Award to Promote Workforce Diversity in Basic Cancer Research (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

03/29/1811/19/20

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHD

03/28/1805/07/21

Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: OBSSRNCINIANIAAANIAIDNIDANIMHNINRNIMHDNCCIH

03/28/1805/07/21

Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH

03/28/1801/07/21

Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NICHDNCINHGRINIANIAAANIAIDNIDCDNIEHSNIMHDNIMHNINRSGMROOARORWH

03/28/1801/07/21

Exploratory/Developmental Clinical Research Grants in Obesity (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIDDKNCINICHDODS

03/27/1809/07/20

SBIR Technology Transfer (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NINDSNCINEINIAAANIDCRNIDANINR

03/06/1804/05/21

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/23/1805/07/21

Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/23/1805/07/21

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

02/13/1811/19/20

Basic Research in Cancer Health Disparities (R01 Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

02/13/1811/19/20

Successor-in-Interest (Type 6 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/26/1801/25/21

Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/25/1801/25/21

Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)

Agency: NIH

Institutions: NCINEINHLBINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMFICNCCIHNCATSORIPOBSSRORWH

01/25/1801/25/21

Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )

Agency: NIH

Institutions: ORWHNCINEINHGRINIANIAAANIAIDNIAMSNIBIBNICHDNIDCDNIDCRNIDDKNIDANIEHSNIGMSNIMHNINDSNINRNIMHDNLMNCCIHORIP

01/25/1809/07/21

Cancer Prevention and Control Clinical Trials Grant Program (R01 Clinical Trial Required)

Agency: NIH

Institutions: NCI

01/05/1801/07/21

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trials Required)

Agency: NIH

Institutions: NCI

01/05/1801/07/21

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NCINIDCRNIBIB

12/21/1701/07/21

Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/20/1701/07/21

Synthetic Biology for Engineering Applications (R01) (Clinical Trial Optional)

Agency: NIH

Institutions: NIBIBNCINCCIH

12/15/1701/07/21

Advancing the Science of Geriatric Palliative Care (R21 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANINRNIMHDNCI

12/15/1709/07/20

Advancing the Science of Geriatric Palliative Care (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: NIANCCIHNINRNIMHDNCINHLBI

12/15/1709/07/20

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/11/1705/07/21

Using Information Technology to Support Systematic Screening and Treatment of Depression in Cancer (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

12/11/1705/07/21

The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

12/06/1703/12/21

The NCI Transition Career Development Award (K22 Independent Clinical Trial Required)

Agency: NIH

Institutions: NCI

12/06/1703/12/21

Cancer Research Education Grants Program - Curriculum or Methods Development (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Cancer Research Education Grants Program - Research Experiences (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Cancer Research Education Grants Program - Courses for Skills Development (R25)

Agency: NIH

Institutions: NCI

12/05/1701/07/21

Multi-Site Studies for System-Level Implementation of Substance Use Prevention and Treatment Services (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIDANCINIAAA

11/30/1711/13/20

Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCINCCIHNIDCRNIDANIMHNIMHDNINDSNINR

11/29/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NIANCINIAAANIDCRNIDDKNIDANIMHNIMHDNINDSNINR

11/29/1709/07/20

NCI Transition Career Development Award to Promote Diversity (K22 - No Clinical Trials)

Agency: NIH

Institutions: NCI

11/20/1701/07/21

NCI Transition Career Development Award to Promote Diversity (K22 Clinical Trial Required)

Agency: NIH

Institutions: NCI

11/20/1701/07/21

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

Agency: NIH

Institutions: NCI

11/17/1701/07/21

NCI Mentored Research Scientist Development Award to Promote Diversity (K01)

Agency: NIH

Institutions: NCI

11/17/1701/07/21

Mechanisms, Models, Measurement, and Management in Pain Research (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NINRNIANIDDKNIDANIDCRNINDSNCCIHNIMHDNCI

11/07/1705/07/21

Mechanisms, Models, Measurement, and Management in Pain Research (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCININRNIANIDANIDCRNINDSNCCIHNIMHD

11/07/1705/07/21

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - No Independent Clinical Trials)

Agency: NIH

Institutions: NCI

10/31/1701/07/21

NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Clinical Trials Required)

Agency: NIH

Institutions: NCI

10/31/1701/07/21

Testing Interventions for Health-Enhancing Physical Activity (R01 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANICHDNIDANIMHDNCCIH

10/17/1701/07/21

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for years 2018, 2019 and 2020 (P50)

Agency: NIH

Institutions: NCINIDCR

10/12/1701/07/21

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed

Agency: NIH

Institutions: NCI

10/12/1710/08/20

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed)

Agency: NIH

Institutions: NCI

10/12/1710/08/20

Developing Interventions for Health-Enhancing Physical Activity (R21/R33 - Clinical Trial Optional)

Agency: NIH

Institutions: ODPNCINIANIAAANIDANCCIH

10/10/1701/07/21

Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (R43/R44 Clinical Trial Not Allowed)

Agency: NIH

Institutions: NCI

10/03/1701/07/21

Multilevel Interventions in Cancer Care Delivery: Follow-up to Abnormal Screening Tests (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCI

09/29/1701/07/21

Research to Improve Native American Health (R21 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNIDCR

09/29/1708/14/20

Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)

Agency: NIH

Institutions: NCINIAAANIDANIEHSNIMHNIMHDOBSSRNINRNIDCR

09/29/1708/14/20

Biology of Lung, and Head and Neck Preneoplasias (R21)

Agency: NIH

Institutions: NCI

08/16/1701/07/21

Biology of Lung, and Head and Neck Preneoplasias (R01)

Agency: NIH

Institutions: NCI

08/15/1701/07/21

The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R01)

Agency: NIH

Institutions: NCI

08/04/1709/07/20

The Interplay of Cell Death Pathways in Cancer Cell Survival and Resistance to Therapy (R21)

Agency: NIH

Institutions: NCI

08/04/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)

Agency: NIH

Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSFIC

08/01/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01)

Agency: NIH

Institutions: NHGRINCINIANICHDNIEHSNINDSNIMHD

08/01/1709/07/20

Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)

Agency: NIH

Institutions: NHGRINCINIANIAIDNICHDNIDCDNIEHSNINDSNIMHD

08/01/1709/07/20

Assay development and screening for discovery of chemical probes or therapeutic agents (R01)

Agency: NIH

Institutions: NCINIAIDNIDCDNIDANIMH

07/27/1709/07/20

Using Small Molecules and Molecular Genetics to Identify Novel Targets and Mechanisms Contributing to Tumor Immune Evasion (R01)

Agency: NIH

Institutions: NCI

07/20/1709/07/20

Discovery of Small Molecule Immunomodulators for Cancer Therapy (R01)

Agency: NIH

Institutions: NCI

07/20/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R21)

Agency: NIH

Institutions: NIANCINIAAANIAMSNIDCRNIDANIMHNIMHDNINDSNINR

06/23/1709/07/20

Multidisciplinary Studies of HIV/AIDS and Aging (R01)

Agency: NIH

Institutions: NIANCINCCIHNIAMSNIDCRNIDANIMHNIMHDNINDSNINR

06/23/1709/07/20

Integration of Individual Residential Histories into Cancer Research (R21)

Agency: NIH

Institutions: NCI

06/22/1709/07/20

Integration of Individual Residential Histories into Cancer Research (R01)

Agency: NIH

Institutions: NCI

06/22/1709/07/20

Leveraging Population-based Cancer Registry Data to Study Health Disparities (R01)

Agency: NIH

Institutions: NCI

05/16/1709/07/20

Leveraging Population-based Cancer Registry Data to Study Health Disparities (R21)

Agency: NIH

Institutions: NCI

05/16/1709/07/20

Mechanisms of Alcohol-associated Cancers (R21)

Agency: NIH

Institutions: NIAAANCI

03/13/1709/07/20

Mechanisms of Alcohol-associated Cancers (R01)

Agency: NIH

Institutions: NIAAANCI

03/13/1709/07/20

Thermal Transport Processes

Agency: NSF

02/22/1708/17/20

Biophotonics

Agency: NSF

02/22/1708/17/20

Fundamental Research to Counter Weapons of Mass Destruction

Agency: DTRA

03/20/1509/30/24
  TOP